A. Tefferi

发表论文 254 篇 · 总被引 5265 次 · h-index 38

代表论文

• CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients (2026 · Blood Cancer Journal · 被引 3)
• Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia. (2026 · Blood Cancer Discovery · 被引 2)
• Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome (2026 · Blood Cancer Journal · 被引 1)
• Thrombosis in primary myelofibrosis: the influence of cohort composition and disease biology (2026 · Blood Advances · 被引 1)
• One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol (2026 · Blood Cancer Journal · 被引 1)
• Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in TP53-mutated myelodysplastic syndromes (2026 · Haematologica · 被引 1)